Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study

Clinical trial NCT00318539 · COMPLETED

Trial details

NCT number: NCT00318539
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obsessive Compulsive Disorder

Start date: 2003-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.